Resultats de la cerca - Andreas Geier

Refinar resultats
  1. 1
    Non-Alcoholic Fatty Liver Disease

    Non-Alcoholic Fatty Liver Disease per Johannes Weiß, Monika Rau, Andreas Geier

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?

    Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier? per Christoph G. Dietrich, Andreas Geier, Uta Merle

    Publicat 2023
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    From the origin of NASH to the future of metabolic fatty liver disease

    From the origin of NASH to the future of metabolic fatty liver disease per Andreas Geier, Dina Tiniakos, Helmut Denk, Michael Trauner

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Animal models of NAFLD from a hepatologist's point of view

    Animal models of NAFLD from a hepatologist's point of view per Daniel Jahn, Stefan Kircher, Heike M. Hermanns, Andreas Geier

    Publicat 2018
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?

    Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network? per Johanna Heitmann, Verena Frings, Andreas Geier, Matthias Goebeler, Andreas Kerstan

    Publicat 2021
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Amyloidosis—the Diagnosis and Treatment of an Underdiagnosed Disease

    Amyloidosis—the Diagnosis and Treatment of an Underdiagnosed Disease per Sandra Ihne, Caroline Morbach, Claudia Sommer, Andreas Geier, Stefan Knop, Stefan Störk

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis

    Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis per Philip P. Becker, Monika Rau, Johannes Schmitt, Carolin Malsch, Christian Hammer, Heike Bantel, Beat Müllhaupt, Andreas Geier

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis

    Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis per Daniel Jahn, D Dorbath, Stefan Kircher, Anika Nier, Ina Bergheim, Kaatje Lenaerts, Heike M. Hermanns, Andreas Geier

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: A precancerous potential?

    Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: A precancerous potential? per Timo Räth, M Roderfeld, Jürgen Graf, Sandra Wagner, Ann‐Kathrin Vehr, Christoph G. Dietrich, Andreas Geier, Elke Roeb

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2☆

    Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2☆ per Christoph G. Dietrich, Andreas Geier, Nina Salein, Frank Lammert, Elke Roeb, Ronald P.J. Oude Elferink, Siegfried Matern, Carsten Gartung

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Spontaneous cholecysto- and hepatolithiasis inMdr2?/? mice: A model for low phospholipid-associated cholelithiasis

    Spontaneous cholecysto- and hepatolithiasis inMdr2?/? mice: A model for low phospholipid-associated cholelithiasis per Frank Lammert, David Q.‐H. Wang, Sonja Hillebrandt, Andreas Geier, Peter Fickert, Michael Trauner, Siegfried Matern, Beverly Paigen, Martin C. Carey

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study

    Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study per Marcin Krawczyk, Monika Rau, Jörn M. Schattenberg, Heike Bantel, Anita Pathil, Münevver Demir, Johannes Kluwe, Tobias Boettler, Frank Lammert, Andreas Geier

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma

    The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma per Andreas Geier, Rocı́o I.R. Macı́as, Dominik Bettinger, Johannes Weiß, Heike Bantel, Daniel Jahn, Ruba Al‐Abdulla, José J.G. Marı́n

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat

    Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat per Andreas Geier, Christoph G. Dietrich, Thomas Gerloff, Jenny Haendly, Gerd A. Kullak‐Ublick, Bruno Stieger, Peter J. Meier, Siegfried Matern, Carsten Gartung

    Publicat 2002
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis

    Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis per Andreas Geier, Christoph G. Dietrich, Sebastian Voigt, Suk-Kyum Kim, Thomas Gerloff, Gerd A. Kullak-Ublick, Johann Lorenzen, Siegfried Matern, Carsten Gartung

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal

    Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal per Johannes Schmitt, Bo Kong, Bruno Stieger, Oliver Tschopp, Simon M. Schultze, Monika Rau, Achim Weber, Beat Müllhaupt, Grace L. Guo, Andreas Geier

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Fecal SCFAs and SCFA‐producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T‐cell activation and advanced disease

    Fecal SCFAs and SCFA‐producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T‐cell activation and advanced disease per Monika Rau, Ateequr Rehman, Marcus Dittrich, Albert K. Groen, Heike M. Hermanns, Florian Seyfried, Niklas Beyersdorf, Thomas Dandekar, Philip Rosenstiel, Andreas Geier

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Non-invasive assessment of NAFLD as systemic disease—A machine learning perspective

    Non-invasive assessment of NAFLD as systemic disease—A machine learning perspective per Ali Canbay, Julia Kälsch, Ursula Neumann, Monika Rau, Simon Hohenester, Hideo A. Baba, Christian Rust, Andreas Geier, Dominik Heider, Jan‐Peter Sowa

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver

    Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell... per Monika Rau, A Schilling, Jan Meertens, Ilona Hering, Johannes Weiß, Christian Jurowich, Theodor Kudlich, Heike M. Hermanns, Heike Bantel, Niklas Beyersdorf, Andreas Geier

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management

    Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management per Liangtao Ye, Julia S. Schneider, Najib Ben Khaled, Peter Schirmacher, Carolin Seifert, L. Frey, Yulong He, Andreas Geier, Enrico N. De Toni, Changhua Zhang, Florian P. Reiter

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: